Sanofi (SNY) Liabilities from Discontinued Operations (2009 - 2026)

Sanofi has disclosed Liabilities from Discontinued Operations across 18 years of filings, most recently posting $229.0 million for Q2 2026.

• In Q2 2026, Liabilities from Discontinued Operations rose 10014.55% year-over-year to $229.0 million; the TTM figure through Jun 2026 stood at $229.0 million (up 10014.55% YoY), while the FY2025 annual figure was $62.9 million, down 97.27% from the prior year.
• Liabilities from Discontinued Operations came in at $229.0 million for Q2 2026 at Sanofi, up from $62.9 million in the prior quarter.
• In the past five years, Liabilities from Discontinued Operations ranged from a high of $2.3 billion in Q4 2024 to a low of $2.3 million in Q2 2025.
• Average Liabilities from Discontinued Operations over 5 years is $331.7 million, with a median of $29.2 million recorded in 2022.
• Year-over-year, Liabilities from Discontinued Operations jumped 16180.41% in 2024 and slumped 97.24% in 2025.
• Over 5 years, Liabilities from Discontinued Operations stood at $10.2 million in 2022, then jumped by 37.1% to $14.0 million in 2023, then jumped by 16180.41% to $2.3 billion in 2024, then sank by 97.24% to $62.9 million in 2025, then jumped by 264.29% to $229.0 million in 2026.
• Per Business Quant data, the three most recent Liabilities from Discontinued Operations figures were $229.0 million in Q2 2026, $62.9 million in Q4 2025, and $2.3 million in Q2 2025.